Ruud Dobber, answers the question, "What is the most surprising thing you've learned about America or Americans since you moved here and took over the US last year?"
Pharm Exec speaks with Ruud Dobber, who is president, AstraZeneca US and executive vice president, North America, to ask him the question "What is the most surprising thing you've learned about America or Americans since you moved here and took over the US last year?"
While Dobber has only been in this position for just over a year, he has provided the viewers with many insights within the healthcare system.
Planning for Unique Challenges Faced by Cell & Gene Therapy Developers
May 8th 2024In an interview with Pharm Exec Associate Editor Don Tracy, Melissa Lattanzi, VP, Emerging Therapies, Cencora, discusses the unique challenges that developers of cell and gene therapies need to plan for when building their channel strategy.
Pricing Climate Impacting Commercial Considerations
May 3rd 2024In this Pharmaceutical Executive video interview, Jesse Mendelsohn, senior vice president at Model N, talks about the influence of Medicare Part D drug price negotiations on manufacturer go-to-market strategies and decision-making, and the industry’s response to the wider dialogue on pricing transparency.